Loading...
Loading...
Shares of
Corgenix Medical CorporationCONX spiked higher by more than 7 percent on Friday after the
World Health Organization approved the company's 15-minute Ebola test.
Corgenix Medical's Ebola test is less accurate than the standard PCR test, but is easy to perform, does not require electricity and offers results within 15 minutes, according to World Health Official spokesman Tarik Jasarevic.
The rollout of the test kits will not begin immediately as the company is still working out costing and needs additional time to complete administrate procedures with the U.S. Food and Drug Administration.
Shares traded recently at $0.28, up $0.02 (7.6 percent).© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in